Intranasal Fresh Mother's Own Milk to Prevent Intraventricular Hemorrhage in Extremely Preterm Infants | MicrobiomeTrials← Back to trialsNCT07812922
Intranasal Fresh Mother's Own Milk to Prevent Intraventricular Hemorrhage in Extremely Preterm Infants
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2027-10
Enrollment target: 67 participants Other microbiome trials you might be interested in
Stroke, Ischemic
To date, the benefit of intravenous thrombolysis is confined within 4.5 hours of onset for acute ischemic stroke (AIS) p…
Shenyang, ChinaEst. completion Dec 15, 2029
Preeclampsia SeverePreeclampsia Postpartum
Participants are recruited for a research study about how lab values change following delivery in people with Preeclamps…
Lexington, United StatesEst. completion Jun 30, 2027